ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3105-6741(Print)
ISSN 3105-675X(Online)

CODEN:LYYAA3
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/lyyaa3
国图集团 CIBTC
进口备案刊号:G015Z125

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
Wanfang Data(万方数据,中国,更新中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)
Enterscholar(恩特学术)

规划申请
Scopus 爱思唯尔·斯高帕斯(荷兰)

SinoMed 中国生物医学文献服务系统
DOAJ 开放获取期刊目录(瑞典)
PubMed 医学文摘数据库(美国)
PubMed Central 医学全文数据(美国)
EMBASE 爱思唯尔·医学文摘(荷兰)
EBSCO 学术文献数据库(美国)
OAJ 全球OA期刊索引(中国)

CABI 国际农业与生物科学中心(英国)
ProQuest 科睿唯安(美国)
Research4Life 世界卫生组织数据库


武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://lcyyyj.scionline2025.com

  往期阅览 · All Issues-> 2026年 · 2026  
临床用药研究2026年第2卷第1期第12-14页,pISSN 3105-6741、eISSN 3105-675X 发布者:Quest Press 发布日期:2026/4/17
Open Access 浏览231

 

基于脾胃理论的小儿功能性腹痛的辨证规律及治疗效果研究


李永佳

达州市第一人民医院,四川达州,635000

摘要:目的:基于“脾常不足”与脾胃为后天之本理论,探讨从脾胃论治小儿常见疾病(以儿童功能性腹痛为代表)的辩证规律及临床疗效。方法:选取2024年11月—2025年10月门诊儿童功能性腹痛患儿60例,随机分为实验组与对照组各30例。对照组给予降教育、饮食调理及枯草杆菌二联活菌颗粒、匹维溴铵片等常规对症治疗;实验组在对照组基础上加用“运脾化滞法”中药基础方(党参、白术、茯苓、陈皮、枳壳、山楂、鸡内金、砂仁、甘草等),随证加减,连续治疗4周。观察指标为:①腹痛相关临床症状评分;②中医证候积分,评价总有效率。结果:在治疗4周后,实验组腹痛症状评分、中医证候积分均明显低于对照组,实验组总有效率93.33%高于对照组73.33%,且能改善纳差、腹胀、神疲乏力等脾虚夹滞相关的症状,P<0.05。结论:从脾胃论治、以运脾化滞为辨证施治核心的辨证施治方案符合小儿“脾常不足”的生理病理特点,可以明显改善儿童功能性腹痛患儿的症状和证候水平,提高总体疗效,提示脾胃理论对于小儿常见疾病有较高的临床指导价值。

关健词:脾胃理论;小儿常见疾病;辨证论治;中医儿科;临床研究
Research on the Diagnostic Patterns and Therapeutic Effects of Common Pediatric Diseases Based on the Spleen and Stomach Theory

Yongjia Li

Dazhou First People's Hospital Dazhou,Sichuan ,635000

Abstract:Objective:Based on the theories of "spleen deficiency" and the spleen-stomach as the foundation of later-nature,this study explores the diagnostic patterns and clinical efficacy of treating common pediatric diseases (represented by childhood functional abdominal pain) from the perspective of spleen-stomach. Methods:Sixty children with functional abdominal pain were selected from outpatient visits between November 2024 and October 2025 and randomly divided into an experimental group and a control group (30 cases each). The control group received health education,dietary adjustments,and conventional symptomatic treatments such as Bacillus subtilis and Enterococcus faecalis dual live bacterial granules and pinaverio bromide tablets. The experimental group was treated with the same regimen plus a traditional Chinese medicine formula(Codonopsis,Atractylodes macrocephala,Poria,Citrus reticulata,Citrus aurantium,Crataegus,Oryx cornuta,Amomum villosum,and Licorice)under the "promoting spleen and eliminating stagnation" approach,with adjustments based on individual symptoms,for 4 consecutive weeks. The observation indicators included:① abdominal pain-related clinical symptom scores;② TCM syndrome scores,and the evaluation of total effective rate. Results:showed that after 4 weeks of treatment,the experimental group had significantly lower abdominal pain symptom scores and TCM syndrome scores compared to the control group,with a total effective rate of 93.33% in the experimental group versus 73.33% in the control group. Additionally,the experimental group demonstrated improved symptoms related to spleen deficiency with stagnation,such as poor appetite,abdominal distension,andfatigue,with P < 0.05. Conclusion:The diagnostic and treatment strategy based on spleen-stomach theory,with "promoting spleen and eliminating stagnation" as the core principle,aligns with the physiological and pathological characteristics of children's "spleen deficiency." It significantly improves symptoms and syndrome levels in children with functional abdominal pain,enhances overall efficacy,and indicates the high clinical guidance value of spleen-stomach theory for common pediatric diseases.


Keywords : Spleen and Stomach Theory;Common Pediatric Diseases;Syndrome Differentiation and Treatment;Traditional Chinese Medicine Pediatrics;clinical research


参考文献
[1] 赵诗琴,董幼祺. 基于“和与运”理论治疗小儿脾胃病验案举隅[J].中国乡村医药,2026,33(03):18-19.
[2] 赵敏君,陆相朋,郑宏. 以脾胃升降理论辨治儿童单纯性肥胖症[J].中医杂志,2025,66(23):2499-2503.
[3] 刘苗苗,袁振华,张蔷,等. 基于“脾胃虚则九窍不通”观点辨治儿童腺样体肥大的思路[J].北京中医药,2025,44(11):1474-1477.
[4] 袁梓潇,石艳红. 鼻炎熏洗方雾化熏洗联合鼻炎方治疗脾胃湿热型儿童过敏性鼻炎临床研究[J].新中医,2025,57(20):77-81.
[5] 付娟,申继强,潘若筠,等. 从“脾胃气化”论治儿童原发性免疫性血小板减少症[J].江西中医药,2025,56(08):29-31+35.
[6] 赵文祎,王彩君,马芬俞. 基于脾胃理论探讨热毒壅盛型针眼的治疗经验[J].中国民间疗法,2025,33(01):13-15.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Macau Sino-Foreign Medical Publishing Ltd.(MSFMP)
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The MSFMP publishes articles under the following open access license.
Quest Press
is a member of the following organizations.